Five US pharmaceutical companies are working to create a vaccine for a new type of coronavirus in a project comparable in scale to the Manhattan nuclear weapons project, White House trade adviser Peter Navarro said in an interview with Fox Business.

On Thursday, it became known about the fifteenth case of coronavirus infection in the United States among American citizens evacuated from Wuhan. The US authorities are taking a number of measures against the virus. Direct flights to China have been discontinued, and foreigners who have recently visited China are no longer allowed to enter the United States. Several hundred Americans evacuated from the Chinese province of Hubei were placed in a two-week quarantine.

“Five large companies here in the United States are working on a large-scale project comparable to the one in Manhattan to create a vaccine. We hope that by November we will have 150 million doses of the vaccine,” Navarro said when asked by the host about US measures to counter the coronavirus.

On December 31, 2019, Chinese authorities informed WHO of an outbreak of unknown pneumonia in the city of Wuhan in Hubei province. Experts have identified the causative agent of the disease – coronavirus 2019-nCoV. To date, only in China, 1,367 people have died from the disease, including two foreigners, almost 6 thousand have recovered, and the number of confirmed cases of infection is approaching 60 thousand. The World Health Organization has given a new type of coronavirus from China the official name – COVID-2019.